The global macroeconomic burden of Alzheimer's disease and other dementias: Estimates and projections for 152 countries or territories

Document Type

Article (peer-reviewed)

Publication Date

9-2024

Abstract

Background: Alzheimer's disease and other dementias (ADODs) severely threaten the wellbeing of older people, their families, and communities, especially with projected exponential growth. Understanding the macroeconomic implications of ADODs for policy making is essential but under-researched. Methods: We used a health-augmented macroeconomic model to calculate the macroeconomic burden of ADODs for 152 countries or territories, accounting for: the effect on labour supply of reduced working hours of informal caregivers; the effect on labour supply of ADODs-related mortality and morbidity; age–sex-specific differences in education, work experience, labour market participations, and informal caregivers; and treatment and formal care costs diverting from savings and investments. Findings: ADODs will cost the world economy 14 513 billion international dollars (INT$, measured in the base year 2020; 95% uncertainty interval [UI] 12 106–17 778) from 2020 to 2050, equivalent to 0·421% (95% UI 0·351–0·515) of annual global GDP. Japan incurs the largest annual GDP loss at 1·463% (1·225–1·790). China (INT$2961 billion [2507–3564]), the USA (INT$2331 billion [1989–2829]), and Japan (INT$1758 billion [1471–2150]) face the largest absolute economic burdens. The economic burden of informal care ranges from 60·97% in high-income countries to 85·45% in lower-middle-income countries, and treatment and formal care costs range from 10·50% in lower-middle-income countries to 30·80% in high-income countries. Interpretation: The macroeconomic burden of ADODs is substantial and unequally distributed across countries and regions. Global efforts to reduce the burden, especially with regard to informal care, are urgently needed.

DOI

10.1016/S2214-109X(24)00264-X

Language

English

Link to Full Text

Share

COinS